Ribociclib (Ribociclib (LEE-011)) With Platinum-based Chemotherapy in Recurrent Platinum Sensitive Ovarian Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lan G Coffman, M.D.
University of Pittsburgh Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
- Upmc Hillman Cancer Center Upper St. Clair
Bethel Park, Pennsylvania, United States
- Upmc Hillman Cancer Center Arnold Palmer at Mountain View
Greensburg, Pennsylvania, United States
- Upmc Hillman Cancer Center Arnold Palmer Medical at Norwin
Irwin, Pennsylvania, United States
- Upmc Hillman Cancer Center Arnold Palmer at Mt Pleasant
Mount Pleasant, Pennsylvania, United States
- Upmc Hillman Cancer Center Passavant (oha)
Pittsburgh, Pennsylvania, United States
- University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
- Upmc Hillman Cancer Center Washington
Washington, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 10 Jun 2017
- Primary completion
- 1 Jun 2020
- Completion
- 1 Aug 2022
- Last update posted
- 7 Sept 2022
- Registered enrollment
- 35
- Registry id
- NCT03056833
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.